ETR:RHK RHÖN-KLINIKUM Aktiengesellschaft (RHK) Stock Price, News & Analysis → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free RHK Stock Alerts €13.00 +1.20 (+10.17%) (As of 04/23/2024 ET) Add Compare Share Share Today's Range€11.40▼€14.0050-Day Range€9.65▼€12.3052-Week Range€9.50▼€13.70Volume51,795 shsAverage Volume43,281 shsMarket Capitalization$870.22 millionP/E Ratio26.53Dividend Yield1.15%Price TargetN/A Stock AnalysisStock AnalysisChartStock AnalysisChart Get RHÖN-KLINIKUM Aktiengesellschaft alerts: Email Address Ad Paradigm PressForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISYou might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.Click here to find out that this 8,788% cryptocurrency is. About RHÖN-KLINIKUM Aktiengesellschaft Stock (ETR:RHK)RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation, ophthalmology, pregnancies and births, accident surgery, dentistry, tumors, neurological conditions, and treatment of thoracic, lung, vascular, nerves and the skeletal system, and heart diseases. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.Read More RHK Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RHK Stock News HeadlinesApril 14, 2024 | americanbankingnews.comRHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK) Shares Up 1.8%May 12, 2022 | finanznachrichten.deZukunft des UKGM: Rhön-Klinikum stellt Einigung infrageApril 24, 2024 | Paradigm Press (Ad)Bitcoin Rockets To Record High But Buy THIS InsteadRecently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…March 25, 2022 | finanznachrichten.deRhön-Klinikum kommt gut durchs Corona-Jahr 2021March 25, 2022 | uk.finance.yahoo.comRHÖN-KLINIKUM AG looks back on successful financial year 2021February 19, 2022 | finanznachrichten.deWarum Technik und Medizin gut zusammenpassen - RHÖN fördert praxisorientierte Studien- und BerufsorientierungFebruary 19, 2022 | finanznachrichten.deRHÖN-KLINIKUM Campus Bad Neustadt ist TAVI-ZentrumSee More Headlines Receive RHK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for RHÖN-KLINIKUM Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeETR SectorMedical Industry Medical Care Facilities Sub-IndustryN/A Current SymbolETR:RHK CUSIPN/A CIKN/A Webwww.rhoen-klinikum-ag.com Phone+49-9-771650FaxN/AEmployees10,017Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)€0.49 Trailing P/E Ratio26.53 Forward P/E Ratio46.69 P/E Growth26.77Net Income$31.92 million Net Margins1.87% Pretax MarginN/A Return on Equity2.62% Return on Assets1.08% Debt Debt-to-Equity Ratio11.89 Current Ratio2.28 Quick Ratio2.12 Sales & Book Value Annual Sales$1.71 billion Price / Sales0.51 Cash Flow€4.73 per share Price / Cash Flow2.75 Book Value€19.14 per share Price / Book0.68Miscellaneous Outstanding Shares66,940,000Free FloatN/AMarket Cap$870.22 million OptionableNot Optionable Beta-0.01 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesDr. Tobias Kaltenbach (Age 64)CEO & Chairman of Management Board Comp: $507kDr. Stefan Stranz (Age 47)CFO & Member of Management Board Comp: $543kDr. Gunther Karl Weiß M.Sc. (Age 56)COO & Member of Management Board Comp: $625kJulian SchmittHead of Investor Relations & TreasuryMr. Eugen MünchChief RepresentativeKey CompetitorsBiotest AktiengesellschaftETR:BIOStratecETR:SBSDrägerwerk AG & Co. KGaAETR:DRW3CompuGroup Medical SE & Co. KGaAETR:COPShop Apotheke EuropeETR:SAEView All Competitors RHK Stock Analysis - Frequently Asked Questions How have RHK shares performed in 2024? RHÖN-KLINIKUM Aktiengesellschaft's stock was trading at €10.00 on January 1st, 2024. Since then, RHK shares have increased by 30.0% and is now trading at €13.00. View the best growth stocks for 2024 here. Is RHÖN-KLINIKUM Aktiengesellschaft a good dividend stock? RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK) pays an annual dividend of €0.15 per share and currently has a dividend yield of 1.36%. The dividend payout ratio is 30.61%. This payout ratio is at a healthy, sustainable level, below 75%. What other stocks do shareholders of RHÖN-KLINIKUM Aktiengesellschaft own? Based on aggregate information from My MarketBeat watchlists, some companies that other RHÖN-KLINIKUM Aktiengesellschaft investors own include Seabridge Gold (SA), iShares Silver Trust (SLV), Walt Disney (DIS), Alamos Gold (AGI), Warriedar Resources (AWV), Bayerische Motoren Werke Aktiengesellschaft (BMW), Anheuser-Busch InBev SA/NV (BUD), Cognex (CGNX), Canadian National Railway (CNI) and Warner Bros. Discovery (DISCK). This page (ETR:RHK) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe #1 Crypto for 2024InvestorPlaceMan Who Predicted 2008: “This Will be Worse.”AltimetryBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RHÖN-KLINIKUM Aktiengesellschaft Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.